Redefine what’s possible in life sciences
To address the changing needs of patients, rising costs, demands for new treatments, and the need for accelerated R&D innovation, life sciences organizations must adopt a modern transformation approach.
Life sciences now
100%
of Biopharma executives agree AI foundation models will enable connections across data types, revolutionizing where and how AI is used
78%
New Science, the best in science and health technology is expected to drive 78% of revenue growth in the next five years
92%
of Biopharma executives agree that data transparency is becoming a competitive differentiator
>50
drugs discovered through AI are progressing through clinical pipelines with two approved treatments projected to generate more than $1 billion in revenue by 2028
60%
of life sciences supply chain executives want better real-time inventory and visibility from external manufacturing partners
Welcome a new era of science and technology in biopharma
Science and technology convergence is rapidly changing the ways we interact with our physical and digital worlds, bringing forth a step change in the speed of industry innovation. Four tech trends are redefining the boundaries and driving this transformation.
How to reinvent life sciences
What’s trending in life sciences
AWS
Veeva
